Cepheid
Most popular related searches
infection control program
methicillin-resistant staphylococcus aureus
infection rate
infection control
infection reducing
healthcare setting
clinical outcome
isolation room
patient safety
patient safety improvement
The Need
Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients.
- Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs1
- Between 2 and 53 million people are estimated to carry MRSA worldwide2
- The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of €7,478 per patient3
The Solution
Xpert® MRSA NxG is an accurate, fast, on-demand PCR test that will help to:
- Optimize the effectiveness of your infection control program and guide the judicious use of barrier precautions
- Guide decolonization practices that reduce infection rates and decrease MRSA transmission
- Help decrease LOS and improve patient and bed management
- Help reduce infection control costs by limiting unnecessary use of isolation rooms and improve clinical outcomes
- Detect the presence of MRSA by targeting both the orfX SCCmec junction and the mecA or mecC genes for a more accurate MRSA detection
- Improve antibiotic stewardship by avoiding unnecessary
The Impact
Shift your lab from reactive to proactive
- Rapidly identify MRSA colonized patients that require contact precautions to reduce the risk of transmission and avoid costly outbreaks
- Improve overall patient safety by reducing the risk of MRSA infection
According to a published German study, implementation of a rapid MRSA screening surveillance program can achieve the following results4
- Decreased infection rate 50%
- Reduced cost 58%
- Total hospital savings € 408,894 in average per year